Sonali Shirali,Rose Dever
Sonali Shirali
Objective: To describe a case of late-onset bipolar affective disorder presenting with acute behavioral disturbance in an individual without prior psychiatric history. ...
An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder [0.03%]
单剂量致幻剂蝇菇治疗伴有重大抑郁症的边缘型人格障碍开放标记研究
Jon E Grant,Sophia Boutouis,Margaret O&#x;Brien et al.
Jon E Grant et al.
Objectives: Borderline personality disorder (BPD) is often comorbid with major depressive disorder (MDD), and there has been a suggestion in the literature that this comorbidity may interfere with MDD treatment response. ...
Venlafaxine Is of Variable Effectiveness in Severe Major Depression, Depending on Patient Treatment Response Expectation [0.03%]
文拉法辛治疗重度抑郁症的效果依赖于患者的疗效期望度而变化
Udo Bonnet
Udo Bonnet
Objective: The importance of contextual factors, such as the patient treatment response expectation for the effectiveness of antidepressants (AD), in the treatment of major depressive disorder (MDD) is still underestimate...
PCSK9 Inhibitors and Bipolar Disorder: A Drug Target Mendelian Randomization Study [0.03%]
PCSK9抑制剂与双向情感障碍：一项药物靶点孟德尔随机化研究
Jin Li,Pei-Sen Yao
Jin Li
Objective: Bipolar disorder (BD) patients remain symptomatic. As lipid-lowering drug targets have been linked to BD risk, we used Mendelian randomization (MR) to assess their therapeutic potential. ...
Antisuicidal Effect of Lamotrigine Augmentation in Treatment-Resistant Depression: A Case Report [0.03%]
拉莫三嗪增效治疗难治性抑郁的抗自杀效果：一例报告
Kimberly Hsiung,Terako Amison
Kimberly Hsiung
Objectives: Treatment-resistant depression (TRD) is a serious public health burden in the United States and comes with an extremely high suicide risk relative to the general population. Lamotrigine, though approved for us...
The Evaluation of Topiramate as a First-Line Medication for Cluster Headache Prophylaxis: A Prospective Observational Cohort Study [0.03%]
拉莫三嗪作为群集性头痛一线预防性药物的效果评估：一项前瞻性队列研究
Javid Shafiyev,Irfan Gahramanov
Javid Shafiyev
Objective: This study evaluated the effectiveness of topiramate monotherapy in treating episodic and chronic cluster headaches and its impact on headache-related disability and quality-of-life areas not sufficiently addre...
Zachary Goodrich,Drew Grehan
Zachary Goodrich
Objective: This case report describes the clinically underrecognized manifestation of delayed-onset akathisia induced by cariprazine occurring 10 weeks after treatment initiation. The secondary objective was to discuss po...
Linezolid-induced Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature [0.03%]
利奈唑胺致可逆性后部脑病综合征1例及文献复习
Jamir Pitton Rissardo,Priya Shah,Kaitlyn Piotrowski et al.
Jamir Pitton Rissardo et al.
Background/aim: Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic condition characterized by vasogenic edema, altered mental status (AMS), seizures, headaches, and visual disturbances. It is commonly ass...
Effect of Low-dose Escitalopram on Cognition and Behavior of Patients With Dementia Without Depression: A Retrospective Study [0.03%]
小剂量艾司西酞普兰对无抑郁的认知症患者认知和行为的影响：回顾性研究
Porimita Chutia,Shailendra Mohan Tripathi,Samiksha Supranjali
Porimita Chutia
Objective: The role of escitalopram on cognition in patients with dementia is inconclusive. In this study effect of low-dose escitalopram on cognition in subjects with dementia without depression is explored. ...
Hematological and Inflammatory Marker Changes Following Electroconvulsive Therapy in Bipolar Mania: A Quasi-Experimental Study [0.03%]
电休克治疗对躁狂症患者血液学和炎症标志物影响的准实验研究
Negar Heidari,Azad Maroufi,Narges Shams-Alizadeh
Negar Heidari
Objective: Neuroinflammation, reflected in hematological and inflammatory biomarkers, plays a role in bipolar disorder. Electroconvulsive therapy (ECT) is effective for treatment-resistant bipolar disorder, but its impact...